 |
|
If you need to get a quote for any product, or have any questions, please fill in the
following contact form, we will contact you within 24 hours. If your have an account with us, click here to login to retrieve your information.
| Your Contact Information (Required *) |
| First Name* |
|
| Last Name* |
|
| E-Mail* |
|
| Company Name* |
|
| Address |
|
| City |
|
| State |
|
| Zip |
|
| Country |
|
| Phone |
|
| Fax |
|
| Web Site |
|
| |
| Products Interested (Browsing products) |
|
| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-0137 |
859518-32-4 |
N-1-Boc-2-Phenylpiperazine |
|
| A1-0327 |
91599-79-0 |
(S)-N-Benzyl-3-hydroxypiperidine |
|
| A1-0855 |
216394-05-7 |
3-Bromo-2-chloropyridine-5-sulfonyl chloride |
|
| A1-2296 |
216766-12-0 |
6-(Trifluoromethyl)pyridin-3-ol |
|
| A1-5084 |
50607-30-2 |
2,4-PIPERADINEDIONE |
|
| A1-6242 |
994-30-9 |
Chlorotriethylsilane |
|
| A1-8409 |
84102-89-6 |
Benzonitrile, 4-formyl-3-hydroxy- |
|
| AS-2018 |
4335-77-7 |
2-Cyclohexylmandelic acid |
|
| AS-3125 |
101-06-4 |
N,N-Dibenzylethanolamine |
|
| JR04-C003 |
76373-22-3 |
(1R)-[1,1'-Binaphthalene]-2,2'-dimethanol |
|
| JR6-L1630 |
1335281-60-1 |
1-(3,5-dimethylisoxazol-4-yl)-4-methyl-2,6,7-trioxa-1-borabicyclo[2.2.2]octan-1-uide |
|
| JR6-L1956 |
908111-35-3 |
2-Bromo-4-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]benzonitrile |
|
| JR6-L2023 |
1184-93-6 |
Butanoic acid, 2-hydroxy-2,3,3-trimethyl-, (2R)- |
|
| JR6-L2110 |
37088-66-7 |
Benzenepropanoic acid, ß-amino-, methyl ester, (ßS)- |
|
| JR6-L2664 |
65031-96-1 |
Butanoic acid, (2S)-2-oxiranylmethyl ester |
|
| JR6-L2812 |
1344687-35-9 |
1H-Pyrazole-3-carboxylic acid, 5-(cyclopentyloxy)- |
|
| JR6-L3546 |
901232-00-6 |
Benzeneethanol, a-(chloromethyl)-4-methoxy-3-methyl-, (aR)- |
|
| JR6-L3907 |
1401711-29-2 |
Pyrrolidine, 2-[bis[4-(hexylthio)phenyl][(trimethylsilyl)oxy]methyl]-, (2S)- |
|
| JR6-L4500 |
1093673-91-6 |
1-Pyrrolidinecarboxamide, 3-hydroxy-N-(4-methoxyphenyl)-, (3S)- |
|
| JR6-L4515 |
1400760-66-8 |
1-Pyrrolidinecarboxylic acid, 3-(4-pyridinylmethoxy)-, 1,1-dimethylethyl ester, (3S)- |
|
| JR6-L4647 |
936648-34-9 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 6-amino-3,4-dihydro-4-oxo-, 1,1-dimethylethyl ester |
|
| JR6-L4812 |
1011482-56-6 |
Dispiro[isoxazole-5(4H),3'(4'H)-[2H-1]benzopyran-2',4''-piperidine]-1''-carboxylic acid, 6'-fluoro-4'-oxo-3-phenyl-, 1,1-dimethylethyl ester |
|
| JR6-L4940 |
1083168-66-4 |
Cyclopropanecarbonitrile, 1-(2,3-dihydro-1H-inden-5-yl)- |
|
| JR6-L5639 |
5582-60-5 |
1-Butyne, 4-(methoxymethoxy)- |
|
| JR6-L5693 |
211388-82-8 |
Benzene, 1-(3-butyn-1-yloxy)-2-nitro- |
|
| JR6-L6152 |
77544-94-6 |
Benzenesulfonamide, N-(3,4-dimethyl-5-isoxazolyl)-4-[[1-(2-hydroxy-5-methylphenyl)ethylidene]amino]- |
|
| JR6-L6163 |
1394293-71-0 |
Benzenesulfonamide, 4-[[[(3,5-dichlorophenyl)amino]carbonyl]amino]-N-(3,4-dimethyl-5-isoxazolyl)- |
|
| JR6-L6560 |
1015794-33-8 |
2,1,3-Benzothiadiazole, 4,7-dibromo-5-(bromomethyl)- |
|
| JR6-L6730 |
141215-31-8 |
[1,2,5]Thiadiazolo[3,4-g]quinoxaline, 4,9-dibromo- |
|
| JR6-L6740 |
931234-51-4 |
3H-Pyrazol-3-one, 1,2-dihydro-2-(3-methylphenyl)-5-(trifluoromethyl)- |
|
| JR6-L6981 |
187088-37-5 |
Benzenemethanamine, a-methyl-a-(trifluoromethyl)-, (aS)- |
|
| JR6-L6984 |
1539320-27-8 |
Benzenemethanamine, a-methyl-a-(trifluoromethyl)-, hydrochloride (1:1), (aS)- |
|
| JR6-L7096 |
441049-20-3 |
1,2-Ethanediol, 1,2-bis(3-fluorophenyl)-, (1S,2S)- |
|
| JR6-L7434 |
1353632-85-5 |
1,2-Propanediol, 3-(3-chloro-1',2',3',6'-tetrahydro[2,4'-bipyridin]-5-yl)-, (2S)- |
|
| JR6-L7515 |
1336504-52-9 |
4-Pyridineethanamine, 3-amino-a-methyl-, (aS)- |
|
| JR6-L8765 |
1315052-43-7 |
7-Octen-2-ol, 1-chloro-, (2R)- |
|
| JR6-L9281 |
1372561-40-4 |
Oxirane, 2-(3-penten-1-yl)-, (2S)- |
|
| JR8-N0254 |
63223-86-9 |
Ginsenoside Rh1 |
|
| JR8-N0580 |
35790-95-5 |
a-hederin |
|
| JR8-N0617 |
7212-44-4 |
nerolidol |
|
| JR8-N0638 |
1630-94-4 |
corynoxeine |
|
| JR8-N0775 |
51415-02-2 |
Chikusetsu saponin a |
|
| JR8-N0875 |
2034-69-7 |
Daphnoretin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Comments |
| |
|
 |
|
|
|
|
|
|